TAZ: a beta-catenin-like molecule that regulates mesenchymal stem cell differentiation
Related Experiment Video
Updated: Aug 13, 2026

TGF-β-mediated Endothelial to Mesenchymal Transition (EndMT) and the Functional Assessment of EndMT Effectors using CRISPR/Cas9 Gene Editing
Published on: February 26, 2021
Jeong-Ho Hong1, Michael B Yaffe
1Center for Cancer Research, Division of Biological Engineering and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Abstract:
Regulating the switch between proliferation and differentiation of mesenchymal stem cells is critical for the development of normal tissues, and the prevention of tumors. How mesenchymal stem cells exit from the cell cycle and differentiate into alternative cell fates such as bone, fat, and muscle, is incompletely understood. We recently discovered that a WW domain-containing molecule, TAZ, functions as a transcriptional modulator to stimulate bone development while simultaneous blocking the differentiation of mesenchymal stem cells into fat. These developmental effects occur through direct interaction between TAZ and the transcription factors Runx2 and PPARgamma, resulting in transcriptional enhancement and repression, respectively of selective programs of gene expression. We propose that TAZ, as well as a highly related molecule YAP, are functionally, though not structurally, similar to beta-catenin and integrate extracellular, membrane, and cytoskeletal-derived signals to influence mesenchymal stem cell fate.
Insights
The WW domain-containing molecule TAZ regulates mesenchymal stem cell fate, promoting bone development while inhibiting fat differentiation by interacting with key transcription factors.
Area of Science:
- Stem cell biology
- Molecular and developmental biology
Background:
- Mesenchymal stem cell (MSC) fate regulation is crucial for tissue development and tumor prevention.
- Understanding how MSCs exit the cell cycle and differentiate into various cell types (bone, fat, muscle) remains incomplete.
Purpose of the Study:
- To investigate the role of the WW domain-containing molecule TAZ in regulating MSC differentiation.
- To elucidate the molecular mechanisms by which TAZ influences cell fate decisions.
Main Methods:
- Investigated TAZ's function as a transcriptional modulator in MSCs.
- Analyzed direct interactions between TAZ and transcription factors Runx2 and PPARgamma.
- Examined the impact of these interactions on gene expression programs.
Main Results:
- TAZ stimulates bone development and simultaneously blocks fat differentiation in MSCs.
- TAZ directly interacts with Runx2 to enhance bone-related gene expression.
- TAZ directly interacts with PPARgamma to repress fat-related gene expression.
Conclusions:
- TAZ acts as a critical regulator of MSC fate, directing differentiation towards bone and away from fat.
- TAZ, similar to YAP, integrates extracellular signals to control MSC fate.
- TAZ's mechanism involves direct modulation of key transcription factors, offering insights into developmental processes and tumorigenesis.
More Related Videos
Related Concept Videos
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
TGF - β Signaling Pathway
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Mesenchymal Stem Cells
Regulation of Angiogenesis and Blood Supply
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

